Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent ...
Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...
Dilgen, a 22-year-old Tottenville resident, has been battling epidermolysis bullosa (EB), a rare, life-threatening genetic ...
Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...
Wellesley will host the eighth annual Plunge for Elodie raises money to benefit research programs for Epidermolysis bullosa, a rare skin disease.
This is the eighth year for these plunges at 21 locations in six different countries. Brooks is the 5-year-old son of former Barboursville residents Brian and Annie Keys Kendrick, and the grandson of ...
Alliance Global Partners raised the firm’s price target on Abeona Therapeutics (ABEO) to $25 from $20 and keeps a Buy rating on the shares ...
In December 2024, Ultragenyx submitted a BLA to the FDA seeking accelerated approval for UX111 (formerly ABO-102) AAV gene therapy as a treatment for patients with Sanfilippo syndrome type A (MPS IIIA ...
The oral mucosa represents a fascinating scenario in the setting of medical research for its peculiar immune mileu. Not only the oral cavity hosts specific immune cells interacting with the local ...
The winner of the annual series between the San Diego Padres and Seattle Mariners will now win the Vedder Cup, a trophy ...
Rock & Roll Hall of Famer and diehard Chicago Cubs fan Eddie Vedder has officially partnered with Major League Baseball, ...
Aimee Lou Wood is having quite the year. While the BAFTA winner is earning rave reviews for her role as Chelsea, the put-upon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results